Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-06 04:14:13 - browse：728

Earlier this month, Intellia Therapeutics announced it was scrapping plans to include U.S.-based sites in one of its mid-stage CRISPR trials after the Food and Drug Administration requested additional data to support including female patients of childbearing potential. The move left many researchers wondering whether the specter of accidental germline transmission — which haunted early gene therapy trials — had now risen over the field of gene editing.

Over the weekend, Intellia sought to assure the gene editing community that no such thing is happening. At a meeting at Cold Spring Harbor Laboratory that drew more than 400 of the field’s top scientists, the company shared more detailed information about studies it has conducted to assess the risks that renegade CRISPR components could be getting into an egg or sperm. These studies demonstrate “that there’s no evidence of vertical germline transmission of those edits,” Jonathan Phillips, head of pharmacology and toxicology at Intellia, said during a presentation Saturday.

Intellia is one of the leading companies working to advance in vivo gene editing therapies. In a landmark study published in the New England Journal of Medicine in 2021, Intellia revealed data from six patients in its trial for a transthyretin amyloidosis therapy — showing for the first time that it was possible to precisely alter the DNA of particular cells within the human body to treat disease with a one-time infusion of CRISPR. Included in the supplementary material was a redacted version of the company’s package requesting authorization to start its clinical trial. It noted that during toxicology studies in non-human primates, Intellia scientists discovered that editing had taken place at low levels in organs other than the liver, including the spleen and adrenal glands. In three out of 12 female monkeys, they also found editing in the animals’ ovaries.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Mass General Brigham physicians react to latest merger step

hotspot

WSS

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Fatty liver disease was alleviated by Lilly’s ‘triple

Scientists uncover potential path to treating deadly childhood tumor

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

A letter from the executive editor: The 2023 STATUS List

entertainment

Wikipedia

Wikipedia

Drug repurposing or repositioning? The language matters

Skip the lead apron during X

Duchenne breakthrough therapy leaves behind pioneering families

Pancreatic cancer is often deadly, but new discoveries are raising hope

Jerome Adams on the need for new antivirals for Covid

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Psychedelics group wrestles with new pharma identity

UnitedHealth, in a surprise, takes aim at Steward’s physician group

As demand for Covid shots wanes, Moderna seeks its next success

Alzheimer's risk factor APOE4 may be a distinct form of the disease

explore

Bird flu in dairy cattle: New measures to control spread to humans

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Study: Black kids more likely to die after surgery than white kids

Pancreatic cancer is often deadly, but new discoveries are raising hope

Fatty liver disease was alleviated by Lilly’s ‘triple

Researchers test human milk's ability to repair gut microbiome

knowledge

Wikipedia

hotspot

explore